SANGAMO THERAPEUTICS, INC. Cash and Cash Equivalents
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Cash and Cash Equivalents of $27.59 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-05-14
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $27.59M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $20.95M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $29.62M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $38.34M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-03-31 | $27.59M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $20.95M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $29.62M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $38.34M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $25.18M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $41.92M 10-Q · filed 2026-05-14 |
| 2024-09-30 | $39.20M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $27.79M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $54.42M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $45.20M 10-Q · filed 2025-11-06 |
| 2023-09-30 | $56.51M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $66.83M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $78.24M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $100.44M 10-Q · filed 2024-11-12 |
| 2022-09-30 | $94.57M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $117.70M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $120.26M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $178.87M 10-Q · filed 2023-11-01 |
| 2021-09-30 | $176.95M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $169.88M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $122.97M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $131.33M 10-Q · filed 2022-11-03 |
| 2020-09-30 | $259.39M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $467.44M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $85.75M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $80.43M 10-Q · filed 2021-11-04 |
| 2019-09-30 | $114.29M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $169.22M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $80.97M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $140.42M 10-Q · filed 2020-11-04 |
| 2018-09-30 | $39.30M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $59.41M 10-Q · filed 2019-08-07 |
| 2018-03-31 | $30.71M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $49.83M 10-Q · filed 2019-11-06 |
| 2017-09-30 | $29.89M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $69.84M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $18.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $22.06M 10-K · filed 2018-03-01 |
| 2016-09-30 | $27.99M 10-Q · filed 2017-11-09 |
| 2016-06-30 | $12.96M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $33.01M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $69.48M 10-K · filed 2018-03-01 |
| 2015-09-30 | $34.29M 10-Q · filed 2016-10-27 |
| 2015-06-30 | $10.77M 10-Q · filed 2016-08-04 |
| 2015-03-31 | $25.26M 10-Q · filed 2016-05-05 |
| 2014-12-31 | $6.03M 10-K · filed 2018-03-01 |
| 2014-09-30 | $11.21M 10-Q · filed 2015-10-30 |
| 2014-06-30 | $99.27M 10-Q · filed 2015-08-06 |
| 2014-03-31 | $126.82M 10-Q · filed 2015-04-28 |
| 2013-12-31 | $10.19M 10-K · filed 2017-02-28 |
| 2013-09-30 | $80.31M 10-Q · filed 2014-10-28 |
| 2013-06-30 | $12.05M 10-Q · filed 2014-07-29 |
| 2013-03-31 | $12.18M 10-Q · filed 2014-05-07 |
| 2012-12-31 | $21.68M 10-K · filed 2016-02-18 |
| 2012-09-30 | $13.72M 10-Q · filed 2013-11-04 |
| 2012-06-30 | $18.48M 10-Q · filed 2013-08-02 |
| 2012-03-31 | $24.49M 10-Q · filed 2013-05-09 |
| 2011-12-31 | $16.77M 10-K · filed 2015-02-25 |
| 2011-09-30 | $21.67M 10-Q · filed 2012-11-02 |
| 2011-06-30 | $8.42M 10-Q · filed 2012-08-03 |
| 2011-03-31 | $6.88M 10-Q · filed 2012-05-07 |
| 2010-12-31 | $10.78M 10-K · filed 2014-02-24 |
| 2010-09-30 | $9.05M 10-Q · filed 2011-11-04 |
| 2010-06-30 | $12.79M 10-Q · filed 2011-08-05 |
| 2009-12-31 | $21.16M 10-K · filed 2013-02-26 |
| 2008-12-31 | $19.41M 10-K · filed 2012-02-23 |